913634-49-8

Upstream product

• 349-88-2 4-Fluorobenzenesulfonyl chloride 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 

Downstream Products

• 893763-33-2 4-fluoro-N-(piperidin-4-yl)benzenesulfonamide 
• 913634-55-6 (R)-N₄-benzyloxy-2-butyl-N₁-{(S)-1-[4-(4-fluoro-benzenesulfonylamino)-piperidine-1-carbonyl]-2,2-dimethyl-propyl}-succinamide 
• 913634-53-4 (R)-3-{(S)-1-[4-(4-fluoro-benzenesulfonylamino)-piperidine-1-carbonyl]-2,2-dimethyl-propylcarbamoyl}-heptanoic acid tert-butyl ester 
• 913634-52-3 N-[1-((S)-2-amino-3,3-dimethyl-butyryl)-piperidin-4-yl]-4-fluoro-benzenesulfonamide hydrochloride 
• 913634-51-2 {(S)-1-[4-(4-fluoro-benzenesulfonylamino)-piperidine-1-carbonyl]-2,2-dimethyl-propyl}-carbamic acid tert-butyl ester 
• 913634-50-1 4-fluoro-N-piperidin-4-yl-benzenesulfonamide hydrochloride 

Relevant academic research and scientific papers

DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS

Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.

Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.

A NOVEL HYDROXAMIC ACID DERIVATIVE AS PEPTIDE DEFORMYLASE INHIBITOR AND MANUFACTURING METHOD THEREOF

The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.